SAPIO, Luigi
 Distribuzione geografica
Continente #
EU - Europa 44
AS - Asia 34
NA - Nord America 22
AF - Africa 3
Totale 103
Nazione #
IT - Italia 23
US - Stati Uniti d'America 22
VN - Vietnam 12
IE - Irlanda 9
HK - Hong Kong 8
DE - Germania 5
IN - India 4
JP - Giappone 4
KE - Kenya 3
CZ - Repubblica Ceca 2
FR - Francia 2
NL - Olanda 2
TR - Turchia 2
CN - Cina 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
TW - Taiwan 1
Totale 103
Città #
Caserta 10
Dublin 9
Hanoi 7
Naples 7
Bhiwandi 3
Dong Ket 3
Frankfurt am Main 3
Nairobi 3
Tokyo 3
Ankara 2
Ashburn 2
Bremen 2
Council Bluffs 2
Dearborn 2
Groningen 2
Omaha 2
Pittsburgh 2
Ann Arbor 1
Athens 1
Baghdad 1
Bengaluru 1
Boardman 1
Cercola 1
Chicago 1
College Station 1
Eboli 1
Kawaguchi 1
Napoli 1
Paris 1
Salerno 1
Taipei 1
Torre Annunziata 1
Wuhan 1
Totale 80
Nome #
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?, file fa5543cd-cc36-4c86-b179-b02994b9b271 41
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A, file dfd1c04c-1cb8-0799-e053-6605fe0a8ddb 16
The influence of the polymer amount on the biological properties of PCL/ZrO2hybrid materials synthesized via sol-gel technique, file dfd1c04b-c3fe-0799-e053-6605fe0a8ddb 15
Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition, file dfd1c04c-f507-0799-e053-6605fe0a8ddb 9
Histone deacetylase inhibitors increase p27Kip1 by affecting its ubiquitin-dependent degradation through Skp2 down-regulation, file dfd1c04b-4201-0799-e053-6605fe0a8ddb 6
Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells, file dfd1c04b-dc21-0799-e053-6605fe0a8ddb 6
INHIBITION OF ONCOGENIC EFFECTS OF LEPTIN BY CAMP ELEVATION IN TRIPLE NEGATIVE BREAST CANCER CELLS, file dfd1c04b-867a-0799-e053-6605fe0a8ddb 3
Cellular response to PCL/ZrO2hybrid materials synthesized via sol-gel as a function of PCL content, file dfd1c04c-314b-0799-e053-6605fe0a8ddb 2
Silica/Polyethylene glycol hybrid materials prepared by a sol-Gel method and containing chlorogenic acid, file dfd1c04c-37db-0799-e053-6605fe0a8ddb 2
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis, file 2da780fc-9fba-4383-848a-0f8f9a057213 1
Inorganic Phosphate as A Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment, file dfd1c04a-c0a8-0799-e053-6605fe0a8ddb 1
Targeting protein kinase A in cancer therapy: an update., file dfd1c04a-c4d0-0799-e053-6605fe0a8ddb 1
Financing Mental Health Facilities During the Economic Recession: Evidence from the Private Finance Initiative Policy in the United Kingdom., file dfd1c04b-8548-0799-e053-6605fe0a8ddb 1
Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons?, file dfd1c04b-8610-0799-e053-6605fe0a8ddb 1
The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is it Time?, file dfd1c04b-867f-0799-e053-6605fe0a8ddb 1
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension, file dfd1c04c-5f4a-0799-e053-6605fe0a8ddb 1
Protein kinase a detection in human urine samples, file dfd1c04d-bb82-0799-e053-6605fe0a8ddb 1
Chlorogenic acid enhances doxorubicin-mediated cytotoxic effect in osteosarcoma cells, file dfd1c04d-c455-0799-e053-6605fe0a8ddb 1
Innovation through Tradition: The Current Challenges in Cancer Treatment, file dfd1c04d-e187-0799-e053-6605fe0a8ddb 1
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines, file dfd1c04d-f808-0799-e053-6605fe0a8ddb 1
Totale 111
Categoria #
all - tutte 507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 1 0 1 1 1 2 0 3 1 1 1 0
2020/20219 1 0 0 0 2 1 1 0 0 0 0 4
2021/20226 0 0 2 0 0 0 0 0 1 0 2 1
2022/202371 1 16 0 0 6 6 6 10 18 5 3 0
2023/20242 0 0 0 0 1 0 0 0 1 0 0 0
Totale 111